Literature DB >> 1847445

Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis.

S R Mumm1, D P Grandgenett.   

Abstract

Integration of retroviral DNA into the host genome requires the activity of retrovirus-encoded integration protein IN. We expressed Rous sarcoma virus (RSV) IN, 286 amino acid residues in length, by using in vitro transcription, followed by in vitro translation in rabbit reticulocyte lysate. The nucleic acid-binding activity of in vitro-translated IN was assessed by using DNA-cellulose affinity chromatography and poly(U)-Sepharose affinity chromatography and by sedimentation analysis in the presence or absence of DNA. In vitro-translated RSV IN exhibited nucleic acid-binding activity similar to that of IN purified from avian myeloblastosis virus. To identify regions of IN which bind to nucleic acids, several deletions of RSV IN were generated. The NH2-terminal 26 amino acids, including the two His residues of a His-Cys box, were not necessary for IN nucleic acid binding with any of the substrates tested. The substrates included native calf thymus DNA, poly(U), and a double-stranded linear DNA molecule with RSV long terminal repeat sequences at its termini. The COOH-terminal region (residues 178 to 286) of IN bound quantitatively (greater than 90%) to poly(U) and to single-stranded circular phi X174 DNA but did not exhibit the double-stranded linear DNA-binding ability of the entire IN molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847445      PMCID: PMC239882     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.

Authors:  D P Grandgenett; A C Vora; R D Schiff
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  Potential metal-binding domains in nucleic acid binding proteins.

Authors:  J M Berg
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

3.  Prevention of NH2-terminal acetylation of proteins synthesized in cell-free systems.

Authors:  R D Palmiter
Journal:  J Biol Chem       Date:  1977-12-25       Impact factor: 5.157

4.  Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains.

Authors:  D Grandgenett; T Quinn; P J Hippenmeyer; S Oroszlan
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

5.  Measurement of macromolecular equilibrium binding constants by a sucrose gradient band sedimentation method. Application to protein-nucleic acid interactions.

Authors:  D E Draper; P H von Hippel
Journal:  Biochemistry       Date:  1979-03-06       Impact factor: 3.162

6.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

7.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

8.  Avian retrovirus pp32 DNA binding protein. Preferential binding to the promoter region of long terminal repeat DNA.

Authors:  R J Knaus; P J Hippenmeyer; T K Misra; D P Grandgenett; U R Müller; W M Fitch
Journal:  Biochemistry       Date:  1984-01-17       Impact factor: 3.162

9.  Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses.

Authors:  R N Eisenman; W S Mason; M Linial
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration.

Authors:  T Fujiwara; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  39 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase.

Authors:  M L Fitzgerald; A C Vora; W G Zeh; D P Grandgenett
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.

Authors:  M H Nymark-McMahon; S B Sandmeyer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  A chimeric Ty3/Moloney murine leukemia virus integrase protein is active in vivo.

Authors:  S L Dildine; J Respess; D Jolly; S B Sandmeyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization.

Authors:  F Yang; O Leon; N J Greenfield; M J Roth
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Ty3 integrase mutants defective in reverse transcription or 3'-end processing of extrachromosomal Ty3 DNA.

Authors:  J Kirchner; S B Sandmeyer
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis.

Authors:  C B Jonsson; G A Donzella; E Gaucan; C M Smith; M J Roth
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

10.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Authors:  C Vink; K H van der Linden; R H Plasterk
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.